glp-1 capsule Clinical Capsules: Semaglutide Becomes the First ORAL Approved for Weight Loss GLP-ONE + Receptor Activator |

This pattern is observed in trials where patients were randomized to either GLP-1RA or SGLT2i treatment

& Chamberlain, L

Breakthrough results for empagliflozin confirm EMPEROR-Preserved as first and only successful trial for heart failure with preserved ejection fraction

Targeted Action: Peptides interact with receptors or signaling pathways that influence specific processes like tissue repair, immune modulation, or mitochondrial function

Mentlein R (2009) Mechanisms underlying the rapid degradation and elimination of the incretin hormones GLP-1 and GIP

The July 2026 meeting is intended to gather expert input on whether these nominated substances should be considered for inclusion on the 503A Bulks List